Cover Story and Editorial Feature Promise of Dexpramipexole in Eosinophil-Associated Diseases
Knopp Biosciences was featured as both the cover story, detailing the company’s recent hypereosinophilic syndrome (HES) trial, as well as in a key editorial entitled “Dexpramipexole: a new antieosinophil drug?” in the August 2, 2018 edition of Blood. The editorial, … Continued